Frequently asked questions

This section covers all the questions that we were asked during the OMC. It will be updated regularly with answers to your questions.

  • Reset
58
Is the inclusion of companies in consortia obligatory and if yes in which degree?

The suppliers are free to decide the form of their participation in the tender. Even tenders from a single entity can be submitted. More info on the eligibility criteria will be included in the Call for Tenders.

57
Could the suppliers be consortia? Could they have partners from other countries?

Yes. More info on the eligibility criteria will be included in the Call for Tenders.

56
Are research centres eligible?

Yes, provided that they can act as market players, meaning that they can provide R&D services against payment and they can invoice the procurers for this provision of services. More info on the eligibility, selection and the on/off award criteria will be included in the Call for Tenders.

55
Who will evaluate the offers?

The offers will be evaluated at least by all five procuring authorities that take part in this joint procurement. More info on the evaluation procedure will be included in the Call for Tenders. See also Q26.

54
Would an international consortium fulfil better the requirements of the tender?

International collaboration between market players/potential suppliers is to be decided by the suppliers. However, this is not a prerequisite set by the call for tenders. Each tender will be evaluated on its own merits. More info on the eligibility/selection/award criteria will be included in the Call for Tenders.

52
When is phase I of the PCP expected to be launched?

The INCAREHEART PCP phase I is expected to be launched in July 2022.

51
What are the TRLs that the developed solution in PCP can reach given that the commercial solution may need certifications/approvals by public bodies?

See answer to Q20.

50
Would it be possible to have the presentations after the end of the meeting?

All presentations and all relevant information will be published on the INCAREHEART project website.

49
So how should the new Medical Device Regulation be managed? Has this also been considered in the PCP time schedule?

The PCP process involves only testing the solution for usability and usefulness by users, but not certification. If the solution uses device or scales to measure clinical parameters, they must already be validated.

Cf also question 6